Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0034097
|
response to cytokine stimulus |
BCL2,BCL2L1,CASP3,CTNNB1, |
7.63E-7 |
GO:0001836
|
release of cytochrome c from mitochondria |
BCL2,BCL2L1,CASP3, |
1.37E-5 |
GO:0008637
|
apoptotic mitochondrial changes |
BCL2,BCL2L1,CASP3, |
3.04E-5 |
GO:0006915
|
apoptosis |
BCL2,BCL2L1,CASP3,CTNNB1, |
3.39E-4 |
GO:0012501
|
programmed cell death |
BCL2,BCL2L1,CASP3,CTNNB1, |
3.54E-4 |
|
GO:0014070
|
response to organic cyclic substance |
BCL2,BCL2L1,CTNNB1, |
4.70E-4 |
GO:0010038
|
response to metal ion |
BCL2,BCL2L1,CTNNB1, |
5.34E-4 |
GO:0008219
|
cell death |
BCL2,BCL2L1,CASP3,CTNNB1, |
5.74E-4 |
GO:0010033
|
response to organic substance |
BCL2,BCL2L1,CASP3,CTNNB1, |
5.79E-4 |
GO:0016265
|
death |
BCL2,BCL2L1,CASP3,CTNNB1, |
5.86E-4 |
GO:0007005
|
mitochondrion organization |
BCL2,BCL2L1,CASP3, |
6.11E-4 |
GO:0045165
|
cell fate commitment |
BCL2,CASP3,CTNNB1, |
6.20E-4 |
GO:0042592
|
homeostatic process |
BCL2,BCL2L1,CASP3,CTNNB1, |
6.53E-4 |
GO:0042127
|
regulation of cell proliferation |
BCL2,BCL2L1,CASP3,CTNNB1, |
7.50E-4 |
GO:0007398
|
ectoderm development |
BCL2,CASP3,CTNNB1, |
1.26E-2 |
GO:0009314
|
response to radiation |
BCL2,BCL2L1,CASP3, |
1.27E-2 |
GO:0010035
|
response to inorganic substance |
BCL2,BCL2L1,CTNNB1, |
1.34E-2 |
GO:0007507
|
heart development |
IFT88,CASP3,CTNNB1, |
1.47E-2 |
GO:0035295
|
tube development |
BCL2,IFT88,CTNNB1, |
1.54E-2 |
GO:0060429
|
epithelium development |
BCL2,CASP3,CTNNB1, |
1.64E-2 |
GO:0001782
|
B cell homeostasis |
BCL2,CASP3, |
3.24E-2 |
GO:0051881
|
regulation of mitochondrial membrane potential |
BCL2,BCL2L1, |
3.24E-2 |
GO:0010559
|
regulation of glycoprotein biosynthetic process |
BCL2,CTNNB1, |
3.24E-2 |
GO:0046902
|
regulation of mitochondrial membrane permeability |
BCL2,BCL2L1, |
3.24E-2 |
GO:0043066
|
negative regulation of apoptosis |
BCL2,BCL2L1,CASP3, |
3.95E-2 |
GO:0000902
|
cell morphogenesis |
BCL2,IFT88,CTNNB1, |
4.00E-2 |
GO:0043069
|
negative regulation of programmed cell death |
BCL2,BCL2L1,CASP3, |
4.06E-2 |
GO:0060548
|
negative regulation of cell death |
BCL2,BCL2L1,CASP3, |
4.08E-2 |
GO:0009725
|
response to hormone stimulus |
BCL2,BCL2L1,CTNNB1, |
4.24E-2 |
GO:0009628
|
response to abiotic stimulus |
BCL2,BCL2L1,CASP3, |
4.27E-2 |
GO:0032989
|
cellular component morphogenesis |
BCL2,IFT88,CTNNB1, |
4.95E-2 |
GO:0009719
|
response to endogenous stimulus |
BCL2,BCL2L1,CTNNB1, |
5.15E-2 |
GO:0051402
|
neuron apoptosis |
BCL2,CASP3, |
5.60E-2 |
GO:0043065
|
positive regulation of apoptosis |
BCL2,BCL2L1,CASP3, |
5.79E-2 |
GO:0043068
|
positive regulation of programmed cell death |
BCL2,BCL2L1,CASP3, |
5.87E-2 |
GO:0010942
|
positive regulation of cell death |
BCL2,BCL2L1,CASP3, |
5.92E-2 |
GO:0043029
|
T cell homeostasis |
BCL2,CASP3, |
6.19E-2 |
GO:0048538
|
thymus development |
BCL2,CTNNB1, |
6.48E-2 |
GO:0042733
|
embryonic digit morphogenesis |
IFT88,CTNNB1, |
7.37E-2 |
GO:0033077
|
T cell differentiation in the thymus |
BCL2,CTNNB1, |
7.96E-2 |
GO:0002260
|
lymphocyte homeostasis |
BCL2,CASP3, |
8.25E-2 |
GO:0007006
|
mitochondrial membrane organization |
BCL2,BCL2L1, |
9.42E-2 |
|
|
|
|
|
|